Linee guida AIAC 2010 per la gestione e il trattamento della - Stopfa

50
6. Cox JL, Canavan TE, Schuessler RB, et
al. The surgical treatment of atrial fibrillation.
II. Intraoperative electrophysiologic
mapping and description of the electrophysiologic
basis of atrial flutter and atrial
fibrillation. J Thorac Cardiovasc Surg
1991;101:406-26.
7. Jais P, Haissaguerre M, Shah DC, et al.
A focal source of atrial fibrillation treated by
discrete radiofrequency ablation. Circulation
1997;95:572-6.
8. Haissaguerre M, Jais P, Shah DC, et al.
Spontaneous initiation of atrial fibrillation by
ectopic beats originating in the pulmonary
veins. N Engl J Med 1998;339:659-66.
9. Jais P, Hocini M, Macle L, et al. Distinctive
electrophysiological properties of
pulmonary veins in patients with atrial fibrillation.
Circulation 2002;106:2479-85.
10. Kumagai K, Ogawa M, Noguchi H, Yasuda
T, Nakashima H, Saku K. Electrophysiologic
properties of pulmonary veins assessed
using a multielectrode basket
catheter. J Am Coll Cardiol 2004;43:2281-
9.
11. Lin WS, Tai CT, Hsieh MH, et al.
Catheter ablation of paroxysmal atrial fibrillation
initiated by non-pulmonary vein ectopy.
Circulation 2003;107:3176-83.
12. Jalife J, Berenfeld O, Mansour M.
Mother rotors and fibrillatory conduction: a
mechanism of atrial fibrillation. Cardiovasc
Res 2002;54:204-16.
13. Wijffels MC, Kirchhof CJ, Dorland R,
Allessie MA. Atrial fibrillation begets atrial
fibrillation. A study in awake chronically instrumented
goats. Circulation 1995;92:
1954-68.
14. Allessie M, Ausma J, Schotten U. Electrical,
contractile and structural remodeling
during atrial fibrillation. Cardiovasc Res
2002;54:230-46.
15. Aime-Sempe C, Folliguet T, Rucker-
Martin C, et al. Myocardial cell death in fibrillating
and dilated human right atria. J Am
Coll Cardiol 1999;34:1577-86.
16. Xu J, Cui G, Esmailian F, et al. Atrial extracellular
matrix remodeling and the maintenance
of atrial fibrillation. Circulation
2004;109:363-8.
17. Pokharel S, van Geel PP, Sharma UC, et
al. Increased myocardial collagen content
in transgenic rats overexpressing cardiac angiotensin-converting
enzyme is related to
enhanced breakdown of N-acetyl-Ser-Asp-
Lys-Pro and increased phosphorylation of
Smad2/3. Circulation 2004;110:3129-35.
18. Nguyen BL, Fishbein MC, Chen LS,
Chen PS, Masroor S. Histopathological substrate
for chronic atrial fibrillation in humans.
Heart Rhythm 2009;6:454-60.
19. Zimmermann M, Kalusche D. Fluctuation
in autonomic tone is a major determinant
of sustained atrial arrhythmias in patients
with focal ectopy originating from
the pulmonary veins. J Cardiovasc Electrophysiol
2001;12:285-91.
20. Fioranelli M, Piccoli M, Mileto GM, et
G ITAL CARDIOL | VOL 12 | SUPPL 1 AL N 1 2011
A RAVIELE ET AL
al. Analysis of heart rate variability five minutes
before the onset of paroxysmal atrial
fibrillation. Pacing Clin Electrophysiol
1999;22:743-9.
21. Dimmer C, Tavernier R, Gjorgov N, Van
Nooten G, Clement DL, Jordaens L. Variations
of autonomic tone preceding onset of
atrial fibrillation after coronary artery bypass
grafting. Am J Cardiol 1998;82:22-5.
22. Bettoni M, Zimmermann M. Autonomic
tone variations before the onset of
paroxysmal atrial fibrillation. Circulation
2002;105: 2753-9.
23. Go AS, Hylek EM, Phillips KA, et al.
Prevalence of diagnosed atrial fibrillation in
adults: national implications for rhythm
management and stroke prevention: the
AntTicoagulation and Risk Factors In Atrial
fibrillation (ATRIA) study. JAMA 2001;285:
2370-5.
24. Murphy NF, Simpson CR, Jhund PS, et
al. A national survey of the prevalence, incidence,
primary care burden and treatment
of atrial fibrillation in Scotland. Heart
2007;93:606-12.
25. Naccarelli GV, Varker H, Lin J, Schulman
KL. Increasing prevalence of atrial fibrillation
and flutter in the United States. Am
J Cardiol 2009;104:1534-9.
26. Miyasaka Y, Barnes ME, Gersh BJ, et
al. Secular trends in incidence of atrial fibrillation
in Olmsted County, Minnesota,
1980 to 2000, and implications on the projections
for future prevalence. Circulation
2006;114:119-25.
27. Wolf PA, Abbott RD, Kannel WB. Atrial
fibrillation as an independent risk factor for
stroke: the Framingham Study. Stroke
1991;22:983-8.
28. Feinberg WM, Blackshear JL, Laupacis
A, Kronmal R, Hart RG. Prevalence, age distribution,
and gender of patients with atrial
fibrillation. Analysis and implications. Arch
Intern Med 1995;155:469-73.
29. Bilato C, Corti MC, Baggio G, et al.
Prevalence, functional impact, and mortality
of atrial fibrillation in an older Italian population
(from the Pro.VA. study). Am J Cardiol
2009;104:1092-7.
30. Kannel WB, Abbott RD, Savage DD,
McNamara PM. Coronary heart disease and
atrial fibrillation: the Framingham Study. Am
Heart J 1983;106:389-96.
31. Psaty BM, Manolio TA, Kuller LH, et al.
Incidence of and risk factors for atrial fibrillation
in older adults. Circulation 1997;96:
2455-61.
32. Wolf PA, Abbott RD, Kannel WB. Atrial
fibrillation: a major contributor to stroke in
the elderly. The Framingham Study. Arch Intern
Med 1987;147:1561-4.
33. Krahn AD, Manfreda J, Tate RB, Mathew -
son FA, Cuddy TE. The natural history of
atrial fibrillation: incidence, risk factors, and
prognosis in the Manitoba Follow-Up Study.
Am J Med 1995;98:476-84.
34. Lloyd-Jones DM, Wang TJ, Leip EP, et
al. Lifetime risk for development of atrial fib-
rillation: the Framingham Heart Study. Circulation
2004;110:1042-6.
35. Heeringa J, van der Kruip DA, Hofman
A, et al. Prevalence, incidence and lifetime
risk of atrial fibrillation: the Rotterdam
study. Eur Heart J 2006;27:949-53.
36. Nieuwlaat R, Capucci A, Camm AJ, et
al; European Heart Survey Investigators.
Atrial fibrillation management: a prospective
survey in ESC member countries: the Euro
Heart Survey on Atrial Fibrillation. Eur Heart
J 2005;26:2422-34.
37. de Vos CB, Pisters R, Nieuwlaat R, et al.
Progression from paroxysmal to persistent
atrial fibrillation: clinical correlates and prognosis.
J Am Coll Cardiol 2010;55:725-31.
38. Nieuwlaat R, Prins MH, Le Heuzey JY,
et al. Prognosis, disease progression, and
treatment of atrial fibrillation patients during
1 year: follow-up of the Euro Heart Survey
on atrial fibrillation. Eur Heart J 2008;29:
1181-9.
39. Levy S, Maarek M, Coumel P, et al.
Characterization of different subsets of atrial
fibrillation in general practice in France: the
ALFA study. The College of French Cardiologists.
Circulation 1999;99:3028-35.
40. Kerr CR, Humphries KH, Talajic M, et
al. Progression to chronic atrial fibrillation after
the initial diagnosis of paroxysmal atrial
fibrillation: results from the Canadian Registry
of Atrial Fibrillation. Am Heart J
2005;149:489-96.
41. Kato T, Yamashita T, Sagara K, Iinuma
H, Fu LT. Progressive nature of paroxysmal
atrial fibrillation. Observations from a 14year
follow-up study. Circ J 2004;68:568-72.
42. Mukamal KJ, Tolstrup JS, Friberg J,
Jensen G, Gronbaek M. Alcohol consumption
and risk of atrial fibrillation in men and
women: the Copenhagen City Heart Study.
Circulation 2005;112:1736-42.
43. Mattioli AV, Bonatti S, Zennaro M,
Melotti R, Mattioli G. Effect of coffee consumption,
lifestyle and acute life stress in the
development of acute lone atrial fibrillation.
J Cardiovasc Med 2008;9:794-8.
44. van der Hooft CS, Heeringa J, van Herpen
G, Kors JA, Kingma JH, Stricker BH.
Drug-induced atrial fibrillation. J Am Coll
Cardiol 2004;44:2117-24.
45. Andrews TC, Reimold SC, Berlin JA,
Antman EM. Prevention of supraventricular
arrhythmias after coronary artery bypass surgery.
A meta-analysis of randomized control
trials. Circulation 1991;84(5 Suppl):III236-
III244.
46. Maisel WH, Rawn JD, Stevenson WG.
Atrial fibrillation after cardiac surgery. Ann
Intern Med 2001;135:1061-73.
47. Wang TJ, Parise H, Levy D, et al. Obesity
and the risk of new-onset atrial fibrillation.
JAMA 2004;292:2471-7.
48. Dublin S, French B, Glazer NL, et al.
Risk of new-onset atrial fibrillation in relation
to body mass index. Arch Intern Med
2006;166:2322-8.
49. Tedrow UB, Conen D, Ridker PM, et al.